Literature DB >> 24091919

Clinical studies of the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.

Hirofumi Makino1,2, Ken-Ei Sada3,4.   

Abstract

In Japan, the Research Committee on Intractable Vasculitides, supported by the Ministry of Health, Labour and Welfare, has been promoting basic and clinical research on vasculitis since 1972. The present Research Committee on Intractable Vasculitides comprises 4 subcommittees under the direction of a Principal Investigator: Basic and Pathological Research Subcommittee, Clinical Research Subcommittee of Small and Medium-sized Vessel Vasculitis, Clinical Research Subcommittee of Large-sized Vessel Vasculitis, and International Cooperation Research Subcommittee. Since 2008, 9 nationwide clinical studies for vasculitis have been conducted and 8 clinical and basic studies are in progress.

Entities:  

Mesh:

Year:  2013        PMID: 24091919      PMCID: PMC3824225          DOI: 10.1007/s10157-013-0845-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  3 in total

1.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Authors:  Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

2.  Risk factors associated with relapse in Japanese patients with microscopic polyangiitis.

Authors:  Takashi Wada; Akinori Hara; Yoshihiro Arimura; Ken-Ei Sada; Hirofumi Makino
Journal:  J Rheumatol       Date:  2011-12-15       Impact factor: 4.666

3.  Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study.

Authors:  Shoichi Ozaki; Tatsuya Atsumi; Taichi Hayashi; Akihiro Ishizu; Shigeto Kobayashi; Shunichi Kumagai; Yasuyuki Kurihara; Manae S Kurokawa; Hirofumi Makino; Hiroko Nagafuchi; Kimimasa Nakabayashi; Norihiro Nishimoto; Machi Suka; Yasuhiko Tomino; Hidehiro Yamada; Kunihiro Yamagata; Masaharu Yoshida; Wako Yumura; K Amano; Y Arimura; K Hatta; S Ito; H Kikuchi; E Muso; H Nakashima; Y Ohsone; Y Suzuki; H Hashimoto; A Koyama; S Matsuo; H Kato
Journal:  Mod Rheumatol       Date:  2011-09-18       Impact factor: 3.023

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.